← FDA Drug Approvals (Drugs@FDA)

COSENTYX

BLA · Biologics License Application · Sponsor: NOVARTIS PHARMS CORP · Approved 2015-01-21

Drug application

FDA Application #
BLA125504
Application type
Biologics License Application
Brand name
COSENTYX
Generic name
SECUKINUMAB
Active ingredients
SECUKINUMAB
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
NOVARTIS PHARMS CORP
Manufacturer
Novartis Pharmaceuticals Corporation
First approval
2015-01-21

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown